TY - JOUR T1 - COVID-19 among nursing staff: Settings and regional differences JF - medRxiv DO - 10.1101/2020.08.14.20174797 SP - 2020.08.14.20174797 AU - Manuela Hoedl AU - Silvia Bauer AU - Doris Eglseer Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/17/2020.08.14.20174797.abstract N2 - Purpose This study was carried out to describe settings of and regional differences in the occurrence of COVID-19 among nursing staff, analysing COVID-19 symptoms, testing and diagnosis procedures.Design We used an online survey to conduct this cross-sectional study among nursing staff in different settings. Data collection was carried out between 12 May and 13 July 2020.Methods The survey included questions that allowed us to collect demographic data (e.g. age), professional qualifications (e.g. nurse, nurse aid) and data regarding the federal states and settings in which the participants worked. In additon, we asked the participants to describe their COVID-19 symptoms, if any were experienced, and the result of COVID-19 testing that they underwent. We used descriptive statistics as well as bivariate analysis methods to calculate differences.Findings More than 80% of the nursing staff (N = 2600) were women, nearly half of these staff members worked in the province of Styria and about three-quarters worked in hospitals. In general, nearly every sixth nurse reported experiencing COVID-19 symptoms. We found statistically significant differences between the settings and the federal provinces with regard to the COVID-19 symptoms reported, but not the test results. The highest porportion of nurses who experienced symptoms worked in lower Austria and in the primary care sector. In total, 1.6% of the participating nurses were tested for COVID-19, as well as about 1% of the nurses who worked in the nursing homes. The highest number of tests were carried out in Vienna followed by the province of Burgenland. In total, all of the nurses who underwent testing were diagnosed with COVID-19.Conclusions Only 1% of the nurses who worked in nursing homes were tested. This group of nurses takes care of the most vulnerable and high-risk group in Austrian society.Therefore, the nursing home staff should have the possibility to be tested even though they did not experience/report any symptoms. The highest prorportion of nurses who experienced symptoms worked in the primary care sector. In the future during a pandemic, health care staff should be comprehensively tested in all settings.Clinical Relevance Providing insights into COVID-19 symptoms experienced by nursing staff workforce and testing for COVID-19 can help us address these aspects in future pandemics more efficiently. In addition, these insights can help to shift the perspectives from critical and acute settings to other settings, e.g. nursing homes. This is an important change in perspectives, as these nurses have worked with the most vulnerable and high-risk group during the COVID-19 pandemic. Ensuring the safety of nursing home residents and providing, high-quality nursing care and interventions can reduce hospital admission rates, decrease health care costs during such pandemics and might even reduce secondary morbidity and mortality.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicable, because of cross-sectional design.Funding StatementThis research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethical commitee of the Medical University of Graz approved the study (32-386 ex 19/20)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to legal issues, data can not be made available. ER -